Use of Ceftazidime-Avibactam in the Treatment of Clinical Syndromes With Limited Treatment Options: A Retrospective Study

Background With rising trends of multi-drug organism infections and the limited availability of new antimicrobials, management of such cases has become a hassle for the clinician. Ceftazidime-Avibactam (CEF-AVI) is evolving as an effective alternative to polymyxins in the management of Carbapenem-Re...

Descripción completa

Detalles Bibliográficos
Autores principales: Radha, Sneha, Warrier, Anup R, Wilson, Arun, Prakash, Shilpa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Infectious Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918332/
https://www.ncbi.nlm.nih.gov/pubmed/36788880
http://dx.doi.org/10.7759/cureus.33623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918332/
https://www.ncbi.nlm.nih.gov/pubmed/36788880
http://dx.doi.org/10.7759/cureus.33623

Ejemplares similares